IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Brasil |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Sudáfrica |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
China |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Ecuador |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Egipto |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Indonesia |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Bangladesh |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Federación de Rusia |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Estados Unidos de América |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Canadá |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Unión Europea |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Chile |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Australia |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Suiza |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Japón |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Corea, República de |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Bolivia, Estado Plurinacional de |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Noruega |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Sudáfrica |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Santa Sede |
08/11/2016-09/11/2016 |
30/01/2017 |
|